Magnetar Financial LLC Makes New Investment in Amdocs Limited $DOX

Magnetar Financial LLC purchased a new position in shares of Amdocs Limited (NASDAQ:DOX) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 44,646 shares of the technology company’s stock, valued at approximately $3,663,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. Scotia Capital Inc. increased its holdings in Amdocs by 3.9% during the 2nd quarter. Scotia Capital Inc. now owns 4,144 shares of the technology company’s stock worth $378,000 after purchasing an additional 156 shares in the last quarter. CENTRAL TRUST Co lifted its holdings in shares of Amdocs by 6.1% in the third quarter. CENTRAL TRUST Co now owns 2,741 shares of the technology company’s stock valued at $225,000 after purchasing an additional 158 shares in the last quarter. Rossby Financial LCC boosted its position in shares of Amdocs by 39.3% during the third quarter. Rossby Financial LCC now owns 620 shares of the technology company’s stock valued at $50,000 after buying an additional 175 shares during the last quarter. AE Wealth Management LLC boosted its position in shares of Amdocs by 4.5% during the second quarter. AE Wealth Management LLC now owns 4,096 shares of the technology company’s stock valued at $374,000 after buying an additional 177 shares during the last quarter. Finally, Blair William & Co. IL grew its holdings in Amdocs by 5.5% during the third quarter. Blair William & Co. IL now owns 3,393 shares of the technology company’s stock worth $278,000 after buying an additional 177 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Stock Performance

NASDAQ:DOX opened at $66.92 on Thursday. Amdocs Limited has a 52-week low of $65.74 and a 52-week high of $95.41. The business’s fifty day moving average is $75.62 and its 200 day moving average is $79.47. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.06 and a current ratio of 1.06. The firm has a market cap of $7.22 billion, a price-to-earnings ratio of 12.94, a PEG ratio of 1.20 and a beta of 0.42.

Amdocs (NASDAQ:DOX) last announced its quarterly earnings results on Tuesday, February 3rd. The technology company reported $1.81 earnings per share for the quarter, beating the consensus estimate of $1.75 by $0.06. The firm had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.15 billion. Amdocs had a return on equity of 20.19% and a net margin of 12.47%.The company’s revenue was up 4.1% on a year-over-year basis. During the same period in the prior year, the business posted $1.66 earnings per share. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. Research analysts predict that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Shareholders of record on Tuesday, March 31st will be paid a $0.569 dividend. The ex-dividend date is Tuesday, March 31st. This represents a $2.28 dividend on an annualized basis and a yield of 3.4%. This is an increase from Amdocs’s previous quarterly dividend of $0.53. Amdocs’s dividend payout ratio is currently 40.81%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on DOX. Wall Street Zen upgraded shares of Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Stifel Nicolaus dropped their price target on Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, February 4th. Wolfe Research reiterated a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Bank of America decreased their price objective on shares of Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a report on Wednesday, November 12th. Finally, Barclays reduced their target price on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a research report on Wednesday, February 4th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $92.33.

Amdocs Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.